Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration
Authors:
- Xiaoling GaoXGXiaoling Gao
- Guangzhi GuGGGuangzhi Gu
- Zhongyang LiuZLZhongyang Liu
- Ni ZengNZNi Zeng
- Quanyin HuQHQuanyin Hu
- Qingxiang SongQSQingxiang Song
- Lei YaoLYLei Yao
- Zhiqing PangZhiqing Pang
- Xinguo JiangXJXinguo Jiang
- Jun ChenJCJun Chen
- Hongzhuan ChenHCHongzhuan Chen
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 32 (36) , 9888-9898
Abstract
No abstract availableKeywords
Funding Information
- National Key Basic Research Program (2007CB935800, 2010CB529800)
- National Natural Science Foundation of China (30801439, 81072592, 30801442)
- Shanghai Science and Technology Committee Rising-Star Program (10QA1404100)
This publication has 62 references indexed in Scilit:
- Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginineBiomaterials, 2011
- Cell penetrating peptide conjugated bioreducible polymer for siRNA deliveryBiomaterials, 2011
- Trigeminal Pathways Deliver a Low Molecular Weight Drug from the Nose to the Brain and Orofacial StructuresMolecular Pharmaceutics, 2010
- Synthetic Skin‐Permeable Proteins Enabling Needleless ImmunizationAngewandte Chemie International Edition, 2010
- The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and PitfallsMolecular Therapy, 2010
- Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic StrokeThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative diseaseBMC Neuroscience, 2008
- Quantum dots for tracking cellular transport of lectin-functionalized nanoparticlesBiochemical and Biophysical Research Communications, 2008
- TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugsBiomaterials, 2008
- New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163Neuro-Oncology, 2008